BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  Business

  Deep dive: Pharma CEO compensation report

  Who is the highest paid CEO in all of pharma? In this special edition, BioSpace examines top paid CEOs and their pay packages.

  June 30, 2026

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Huntington’s disease

  Skyhawk CEO hopes FDA’s new uniQure position will translate to Huntington’s pill

  A recent FDA reversal sparked new hope for patients with Huntington’s disease. Flying under the radar, Skyhawk Therapeutics revealed 12-month functional data from a midstage trial of its own candidate showing improvements on a key disease measurement scale.

  June 30, 2026

   · 

  4 min read

   · 

  Heather McKenzie
• Press Releases

  Study Reveals How Leukemia Cells Enter and Damage Lungs

  June 30, 2026

   · 

  7 min read
• Press Releases

  Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville

  June 30, 2026

   · 

  3 min read
• Press Releases

  Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

  June 30, 2026

   · 

  9 min read
• Press Releases

  Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

  June 30, 2026

   · 

  3 min read
• Press Releases

  Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

  June 30, 2026

   · 

  13 min read
• Press Releases

  Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

  June 30, 2026

   · 

  8 min read
• Press Releases

  DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

  June 30, 2026

   · 

  5 min read
• Press Releases

  FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

  June 30, 2026

   · 

  5 min read